Allergen immunotherapy practice in the United States: Guidelines, measures, and outcomes

Annals of Allergy, Asthma and Immunology

Volumn 107, Issue 4, 2011, Pages 289-299

  Cox, Linda ^a   Esch, Robert E ^b   Corbett, Mark ^c   Hankin, Cheryl ^d   Nelson, Michael ^e   Plunkett, Greg ^f  

^a NOVA SOUTHEASTERN UNIVERSITY   (United States)

^b Greer Laboratories Inc   (United States)

^c Allergy Care in Louisville   (United States)

^d BioMedEcon LLC   (United States)

^e WALTER REED ARMY MEDICAL CENTER   (United States)

^f ALK Abello Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; FUNGUS ANTIGEN; GLYCEROL; HUMAN SERUM ALBUMIN; PLACEBO; POLLEN ANTIGEN; SODIUM CHLORIDE;

ALLERGIC RHINITIS; ANT; ASTHMA; CLINICAL PRACTICE; COCKROACH; COST EFFECTIVENESS ANALYSIS; DOSE RESPONSE; DRUG CONTROL; DRUG COST; DRUG EFFICACY; DRUG MANUFACTURE; DRUG POTENCY; DRUG SAFETY; GRASS; HEALTH CARE POLICY; HEALTH CARE QUALITY; HUMAN; IMMUNOTHERAPY; MEDICAL SOCIETY; MOULD; OPTIMAL DRUG DOSE; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SPECIFIC ALLERGEN IMMUNOTHERAPY; SUBCUTANEOUS IMMUNOTHERAPY; UNITED STATES; UNSPECIFIED SIDE EFFECT;

EID: 80053363373     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2011.06.018     Document Type: Review

References (39)

1. L. Cox, and L. Jacobsen Comparison of allergen immunotherapy practice patterns in the United States and Europe Ann Allergy Asthma Immunol 103 2009 451 459
2. S.Y. Lin, P.C. Lay, L.F. Hughes, and R. Bass The safety of multi-dose vials in allergy immunotherapy Otolaryngol Head Neck Surg 139 2008 195 197 (Pubitemid 352010416)
3. L. Cox, J. Li, R. Lockey, and H. Nelson Allergen immunotherapy: a practice parameter second update J Allergy Clin Immunol 120 2007 S25 S85 (Pubitemid 47313519)
4. Compounding personnel should be appropriately trained health professionals including, but not limited to, registered nurses, licensed practical nurses, medical technicians, medical assistants, physician assistants, advanced practice nurses and physicians J Allergy Clin Immunol 123 2009 1421
5. USP 797 Guidebook to Pharmaceutical CompoundingSterile Preparations http://www.usp.org/products/797Guidebook/ Accessed March 21, 2010
6. A.G. Letz, M.S. Tankersley, J.P. Dice, and R.W. England Monitoring bacteriostasis in allergen extract mixing: 10 years of culture data J Allergy Clin Immunol 123 2009 1175 1176
7. P.C. Lay, R. Bass, L.F. Hughes, and S.Y. Lin Risks of allergy vial contamination: comparison of mixing in-office versus under ventilation hood Otolaryngol Head Neck Surg 139 2008 364 366
8. P.C. Lay, R. Bass, and S.Y. Lin Allergen vial mixing and immunotherapy: risks of infections and vial contamination Otolaryngol Head Neck Surg 137 2007 243 245 (Pubitemid 47102436)
9. L. Cox, H. Nelson, and R. Lockey Allergen immunotherapy: a practice parameter third update J Allergy Clin Immunol 127 1 suppl 2011 S1 S55
10. N.R. Niemeijer, H.F. Kauffman, W. van Hove, A.E. Dubois, and J.G. de Monchy Effect of dilution, temperature, and preservatives on the long-term stability of standardized inhalant allergen extracts Ann Allergy Asthma Immunol 76 1996 535 540 (Pubitemid 26195757)
11. E. Varjonen, F. Bjorksten, and J. Savolainen Stability of cereal allergens Clin Exp Allergy 26 1996 436 443 (Pubitemid 26122845)
12. H.M. Vijay, N.M. Young, and I.L. Bernstein Studies on Alternaria allergens, VI: stability of the allergen components of Alternaria tenuis extracts under a variety of storage conditions Int Arch Allergy Appl Immunol 83 1987 325 328 (Pubitemid 17079725)
13. T.E. Van Metre Jr., G.L. Rosenberg, S.K. Vaswani, S.R. Ziegler, and N.F. Adkinson Pain and dermal reaction caused by injected glycerin in immunotherapy solutions J Allergy Clin Immunol 97 1996 1033 1039 (Pubitemid 26154199)
14. C.W. Calabria, C.A. Coop, and M. Tankersley The GILL study: glycerin-induced local reactions in immunotherapy J Allergy Clin Immunol 121 2008 222 226
15. T.J. Grier, D.M. LeFevre, E.A. Duncan, and R.E. Esch Stability of standardized grass, dust mite, cat, and short ragweed allergens after mixing with mold or cockroach extracts Ann Allergy Asthma Immunol 99 2007 151 160 (Pubitemid 47264776)
16. T.R. Kordash, M.J. Amend, S.L. Williamson, J.K. Jones, and G.A. Plunkett Effect of mixing allergenic extracts containing Helminthosporium, D. farinae, and cockroach with perennial ryegrass Ann Allergy 71 1993 240 246 (Pubitemid 23276872)
17. H.S. Nelson Effect of preservatives and conditions of storage on the potency of allergy extracts J Allergy Clin Immunol 67 1981 64 69 (Pubitemid 11155095)
18. P.S. Norman, and D.G. Marsh Human serum albumin and Tween 80 as stabilizers of allergen solutions J Allergy Clin Immunol 62 1978 314 319 (Pubitemid 9059861)
19. H.S. Nelson, D. Ikle, and A. Buchmeier Studies of allergen extract stability: the effects of dilution and mixing J Allergy Clin Immunol 98 1996 382 388 (Pubitemid 26326132)
20. G. Plunkett Stability of major allergen proteins in extract mixes diluted in human serum Albumin (HSA), normal saline (NSP), or glycerin (GLY) J Allergy Clin Immunol 119 2007 S105
21. G. Plunkett, and M. Schell Stability of allergen extracts diluted in saline or human serum albumin solutions [abstract] Ann Allergy Asthma Immunol 105 2010 A1 A140
22. R.E. Esch Specific immunotherapy in the U.S.A.: general concept and recent initiatives Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M 2003 17 22 discussion 3
23. R.E. Esch Formulation of therapeutic allergen mixtures problems associated with the number, proportion, and enzymatic activities of allergens Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M 1999 57 61 discussion 73-8
24. R.E. Esch Role of proteases on the stability of allergenic extracts Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M 1992 171 177 discussion 79
25. T.J. Grier, D.M. LeFevre, E.A. Duncan, and R.E. Esch Stability and mixing compatibility of dog epithelia and dog dander allergens Ann Allergy Asthma Immunol 103 2009 411 417
26. R.E. Esch Allergen immunotherapy: what can and cannot be mixed? J Allergy Clin Immunol 122 2008 659 660
27. H.S. Nelson Multiallergen immunotherapy for allergic rhinitis and asthma J Allergy Clin Immunol 123 2009 763 769
28. J.E. Slater Standardized allergen vaccines in the United States Clin Allergy Immunol 21 2008 273 281
29. J.E. Slater, and R.W. Pastor The determination of equivalent doses of standardized allergen vaccines J Allergy Clin Immunol 105 2000 468 474 (Pubitemid 30169903)
30. L. Cox Standardized allergen extracts: past, present and future Expert Rev Clin Immunol 1 2005 579 588
31. US Congressional Budget Office The Long-Term Outlook For Health Care Spending November 2007 US Congressional Budget Office Washington, DC
32. US Congressional Budget Office Research on the Comparative Effectiveness of Medical Treatments December 2007 US Congressional Budget Office Washington, DC http://www.cbo.gov/ftpdocs/88xx/doc8891/12-18-ComparativeEffectiveness.pdf Accessed April 17, 2011
33. US Department of Health and Human Services Federal Coordinating Council for Comparative Effectiveness Research: Report to the President and the Congress June 20, 2009 US Dept of Health and Human Services Washington, DC http://www.hhs.gov/recovery/programs/cer/cerannualrpt.pdf Accessed April 17, 2011
34. L. Jacobsen, B. Niggemann, and S. Dreborg Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study Allergy 62 2007 943 948 (Pubitemid 47037870)
35. J.G. Donahue, D.K. Greineder, L. Connor-Lacke, C.F. Canning, and R. Platt Utilization and cost of immunotherapy for allergic asthma and rhinitis Ann Allergy Asthma Immunol 82 1999 339 347 (Pubitemid 29203282)
36. C.S. Hankin, L. Cox, and D. Lang Allergen immunotherapy and health care cost benefits for children with allergic rhinitis: a large-scale, retrospective, matched cohort study Ann Allergy Asthma Immunol 104 2010 79 85
37. C.S. Hankin, L. Cox, and D. Lang Allergy immunotherapy among Medicaid-enrolled children with allergic rhinitis: patterns of care, resource use, and costs J Allergy Clin Immunol 121 2008 227 232
38. Z. Wang, C.S. Hankin, L. Cox, and A. Bronstone Allergen immunotherapy significantly reduces healthcare costs among U.S. adults with allergic rhinitis: a retrospective matched cohort study jointly funded by the AAAAI and ACAAI J Allergy Clin Immunol 127 2011 AB150
39. S.Y. Lin, S.M. Houser, and H.P. Rodriguez The implications of regulatory guidelines on allergen vial mixing for the practicing otolaryngologist Otolaryngol Head Neck Surg 136 2007 1017 1018